These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6790999)

  • 1. The metabolism of naltrexone in man.
    Wall ME; Brine DR; Perez-Reyes M
    NIDA Res Monogr; 1981; 28():105-31. PubMed ID: 6790999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and disposition of naltrexone in man after oral and intravenous administration.
    Wall ME; Brine DR; Perez-Reyes M
    Drug Metab Dispos; 1981; 9(4):369-75. PubMed ID: 6114837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys.
    Reuning RH; Ashcraft SB; Wiley JN; Morrison BE
    Drug Metab Dispos; 1989; 17(6):583-9. PubMed ID: 2575491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone disposition in man after subcutaneous administration.
    Wall ME; Perez-Reyes M; Brine DR; Cook CE
    Drug Metab Dispos; 1984; 12(6):677-82. PubMed ID: 6150815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics.
    Verebey K
    NIDA Res Monogr; 1981; 28():147-58. PubMed ID: 6791001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.
    Malspeis L; Bathala MS; Ludden TM; Bhat HB; Frank SG; Sokoloski TD; Morrison BE; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN) in human plasma, red blood cells, saliva and urine by gas liquid chromatography.
    Verebey K
    NIDA Res Monogr; 1981; 28():36-51. PubMed ID: 6791012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.
    Taylor SM; Rodgers RM; Lynn RK; Gerber N
    J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat.
    Dayton HE; Inturrisi CE
    Drug Metab Dispos; 1976; 4(5):474-8. PubMed ID: 10147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the oral, intravenous, and subcutaneous administration of 3H-naltrexone to normal male volunteers.
    Perez-Reyes M; Wall ME
    NIDA Res Monogr; 1981; 28():93-101. PubMed ID: 6791016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of radioactivity following administration of [15,16-3H]naltrexone to rats and guinea pigs.
    Ludden TM; Bathala MS; Malspeis L; Drum MA; Reuning RH
    Drug Metab Dispos; 1978; 6(3):321-8. PubMed ID: 26554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The identification and measurement of two new metabolites of naltrexone in human urine.
    Cone EJ; Gorodetzky CW; Darwin WD; Carroll FI; Brine GA; Welch CD
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):413-33. PubMed ID: 674824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol plasma levels in schizophrenic patients after large oral doses of naltrexone.
    Verebey K; Mulé SJ
    NIDA Res Monogr; 1979; 27():296-301. PubMed ID: 121346
    [No Abstract]   [Full Text] [Related]  

  • 14. Analytical methods for quantitative and qualitative analysis of naltrexone and metabolites in biological fluids.
    Wall ME; Brine DR
    NIDA Res Monogr; 1981; 28():52-65. PubMed ID: 6791013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
    Meyer MC; Straughn AB; Lo MW; Schary WL; Whitney CC
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):15-9. PubMed ID: 6469932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of naltrexone and 6-beta-naltrexol in human plasma following implantation of naltrexone pellets using gas chromatography-mass spectrometry.
    Toennes SW; Kauert GF; Grüsser SM; Jäkel W; Partecke G
    J Pharm Biomed Anal; 2004 Apr; 35(1):169-76. PubMed ID: 15030891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and identification of a new metabolite of naltrexone in human blood and urine.
    Verebely K; Chedekel MA; Mule SJ; Rosenthal D
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):67-84. PubMed ID: 1188187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.
    Misra AL; Bloch R; Vardy J; Mulé SJ; Verebely K
    Drug Metab Dispos; 1976; 4(3):276-80. PubMed ID: 6233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone biotransformation and incidence of subjective side effects: a preliminary study.
    King AC; Volpicelli JR; Gunduz M; O'Brien CP; Kreek MJ
    Alcohol Clin Exp Res; 1997 Aug; 21(5):906-9. PubMed ID: 9267542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic reduction of naltrexone II. In vitro studies using liver from guinea pig, monkey and rat.
    Malspeis L; Ludden TM; Bathala MS; Morrison BE; Feller DR; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):393-406. PubMed ID: 822483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.